-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, E0JSXfj9m5hTU4y2nmZvJKbAwp7eO9I+FTkdXvDDt8iDJHV/ITPiHuV4+2bGwU6a duVxtWOtQI4uEeJhOCYm1g== 0000950135-07-000948.txt : 20070220 0000950135-07-000948.hdr.sgml : 20070219 20070220112350 ACCESSION NUMBER: 0000950135-07-000948 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20070220 DATE AS OF CHANGE: 20070220 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: MICROMET, INC. CENTRAL INDEX KEY: 0001131907 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 522243564 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-79337 FILM NUMBER: 07634245 BUSINESS ADDRESS: STREET 1: 2110 RUTHERFORD STREET 2: ROAD CITY: CARLSBAD STATE: CA ZIP: 92008 BUSINESS PHONE: 7604944200 MAIL ADDRESS: STREET 1: 2110 RUTHERFORD STREET 2: ROAD CITY: CARLSBAD STATE: CA ZIP: 92008 FORMER COMPANY: FORMER CONFORMED NAME: CANCERVAX CORP DATE OF NAME CHANGE: 20010108 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: INTERNATIONAL BIOTECHNOLOGY TRUST PLC CENTRAL INDEX KEY: 0000942257 IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: FIVE ARROWS HOUSE STREET 2: ST SWITHINS LN CITY: LONDON EC4N 8NR MAIL ADDRESS: STREET 1: FIVE ARROWS HOUSE STREET 2: ST SWITHINS LN CITY: LONDON EC4N 8NR SC 13G 1 b64207misc13g.txt MICROMET, INC UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. __) MICROMET, INC. -------------- (Name of Issuer) Common Stock, Par Value $0.00004 Per Share ------------------------------------------ (Title of Class of Securities) 13738Y107 ------------ (CUSIP Number) December 31, 2006 ----------------------------------------------------- (Date of Event Which Requires Filing of this Statement) CHECK THE APPROPRIATE BOX TO DESIGNATE THE RULE PURSUANT TO WHICH THIS SCHEDULE IS FILED: [ ] Rule 13d-1(b) [X] Rule 13d-1(c) [ ] Rule 13d-1(d) CUSIP No. 13738Y107 13G Page 2 of 9 Pages - -------------------------------------------------------------------------------- 1. NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) INTERNATIONAL BIOTECHNOLOGY TRUST PLC - -------------------------------------------------------------------------------- 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) [ ] (b) [ ] - -------------------------------------------------------------------------------- 3. SEC USE ONLY - -------------------------------------------------------------------------------- 4. CITIZENSHIP OR PLACE OF ORGANIZATION UNITED KINGDOM - -------------------------------------------------------------------------------- 5. SOLE VOTING POWER --0-- NUMBER OF ------------------------------------------------ SHARES 6. SHARED VOTING POWER 1,907,390 BENEFICIALLY ------------------------------------------------ OWNED BY EACH 7. SOLE DISPOSITIVE POWER --0-- REPORTING ------------------------------------------------ PERSON WITH 8. SHARED DISPOSITIVE POWER 1,907,390 - -------------------------------------------------------------------------------- 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,907,390 - -------------------------------------------------------------------------------- 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) [ ] - -------------------------------------------------------------------------------- 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 6.1% - -------------------------------------------------------------------------------- 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO - -------------------------------------------------------------------------------- CUSIP No. 29425Y101 13G Page 3 of 9 Pages - -------------------------------------------------------------------------------- 1. NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) SV LIFE SCIENCES MANAGERS LLP - -------------------------------------------------------------------------------- 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) [ ] (b) [ ] - -------------------------------------------------------------------------------- 3. SEC USE ONLY - -------------------------------------------------------------------------------- 4. CITIZENSHIP OR PLACE OF ORGANIZATION UNITED KINGDOM - -------------------------------------------------------------------------------- 5. SOLE VOTING POWER --0-- NUMBER OF ------------------------------------------------ SHARES 6. SHARED VOTING POWER 1,907,390 BENEFICIALLY ------------------------------------------------ OWNED BY EACH 7. SOLE DISPOSITIVE POWER --0-- REPORTING ------------------------------------------------ PERSON WITH 8. SHARED DISPOSITIVE POWER 1,907,390 - -------------------------------------------------------------------------------- 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,907,390 - -------------------------------------------------------------------------------- 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) [ ] - -------------------------------------------------------------------------------- 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 6.1% - -------------------------------------------------------------------------------- 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) PN - -------------------------------------------------------------------------------- CUSIP No. 29425Y101 13G Page 4 of 9 Pages - -------------------------------------------------------------------------------- ITEM 1(a). NAME OF ISSUER: Micromet, Inc. (the "Issuer") ITEM 1(b). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES: 2110 Rutherford Road Carlsbad, CA 92008 ITEM 2(a). NAME OF PERSON FILING: This statement is being filed by the following persons: (i) International Biotechnology Trust plc ("IBT"); and (ii) SV Life Sciences Managers LLP ("Managers"). IBT and Managers are sometimes individually referred to herein as a "Reporting Person" and collectively as the "Reporting Persons." ITEM 2(b). ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE: Address for IBT: 31 Gresham Street London, EC2V 7QA United Kingdom Address for Managers: 71 Kingsway London, WC2B 6ST United Kingdom ITEM 2(c). CITIZENSHIP: IBT - United Kingdom Managers - United Kingdom ITEM 2(d). TITLE OF CLASS OF SECURITIES: Common Stock, par value $0.00004 per share ITEM 2(e). CUSIP NUMBER: 13738Y107 ITEM 3. Not applicable. CUSIP No. 29425Y101 13G Page 5 of 9 Pages - -------------------------------------------------------------------------------- ITEM 4. OWNERSHIP. Provide the following information regarding the aggregate number and percentage of the class of securities of the Issuer identified in Item 1. For IBT and Managers: (a) Amount beneficially owned: 1,907,390 shares of Common Stock (b) Percent of class: 6.1% (c) Number of shares as to which such person has: (i) Sole power to vote or to direct the vote: --0-- (ii) Shared power to vote or to direct the vote: 1,907,390 (iii) Sole power to dispose or to direct the disposition of: --0-- (iv) Shared power to dispose or to direct the disposition of: 1,907,390 ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS. Not applicable. ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON. IBT is the record owner of 1,907,390 shares of Common Stock of the Issuer ("Record Shares"). By virtue of the contractual relationship between IBT and Managers, Managers may be deemed to own beneficially the Record Shares. Managers expressly disclaims beneficial ownership of any shares of such shares of Common Stock. ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY. Not applicable. ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP. Not applicable. ITEM 9. NOTICE OF DISSOLUTION OF GROUP. Not applicable. CUSIP No. 29425Y101 13G Page 6 of 9 Pages - -------------------------------------------------------------------------------- ITEM 10. CERTIFICATION. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. CUSIP No. 29425Y101 13G Page 7 of 9 Pages - -------------------------------------------------------------------------------- SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. February 16, 2007 ----------------- Date INTERNATIONAL BIOTECHNOLOGY TRUST PLC /s/ Nick Coleman -------------------------------------- Signature Nick Coleman, Authorized Signatory -------------------------------------- Name/Title SV LIFE SCIENCES MANAGERS LLP /s/ Nick Coleman -------------------------------------- Signature Nick Coleman, Authorized Signatory -------------------------------------- Name/Title CUSIP No. 29425Y101 13G Page 8 of 9 Pages - -------------------------------------------------------------------------------- EXHIBIT INDEX Exhibit 1. Joint Filing Agreement as required by Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended. CUSIP No. 29425Y101 13G Page 9 of 9 Pages - -------------------------------------------------------------------------------- EXHIBIT 1 JOINT FILING AGREEMENT PURSUANT TO RULE 13d-1(k)(1) The undersigned acknowledge and agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing statements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him, her or it contained herein, but shall not be responsible for the completeness and accuracy of the information concerning the other entities or persons, except to the extent that he, she or its knows or has reason to believe that such information is inaccurate. February 16, 2007 -------------------------------------- Date INTERNATIONAL BIOTECHNOLOGY TRUST PLC /s/ Nick Coleman -------------------------------------- Signature Nick Coleman, Authorized Signatory -------------------------------------- Name/Title SV LIFE SCIENCES MANAGERS LLP /s/ Nick Coleman -------------------------------------- Signature Nick Coleman, Authorized Signatory -------------------------------------- Name/Title -----END PRIVACY-ENHANCED MESSAGE-----